Jpmorgan Chase & CO Armata Pharmaceuticals, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$504,6420.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$239,8270.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$224,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$168,8550.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $81M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...